Insights into the molecular nature of magnesium homeostasis

American Journal of Physiology - Renal Physiology

Volumn 286, Issue 4 55-4, 2004, Pages

  Konrad, Martin ^a   Schlingmann, Karl P ^a   Gudermann, Thomas ^b  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Genetics; Hypomagnesemia; Long transient receptor potential; Secondary hypocalcemia

Indexed keywords

CALCIUM; MAGNESIUM; NUCLEIC ACID; TRANSIENT RECEPTOR POTENTIAL CHANNEL;

CALCIUM ABSORPTION; CONCENTRATION (PARAMETERS); GENE; HENLE LOOP; HOMEOSTASIS; HUMAN; HYPOCALCEMIA; HYPOMAGNESEMIA; INBORN ERROR OF METABOLISM; ION TRANSPORT; KIDNEY DISTAL TUBULE; KIDNEY TUBULE ABSORPTION; MAGNESIUM METABOLISM; MOLECULAR BIOLOGY; NEUROMUSCULAR FUNCTION; PRIORITY JOURNAL; PROTEIN STABILITY; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW;

EID: 1642390943     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00312.2003     Document Type: Review

References (77)

1. Achard JM, Warnock DG, Disse-Nicodeme S, Fiquet-Kempf B, Corvol P, Fournier A, and Jeunemaitre X. Familial hyperkalemic hypertension: phenotypic analysis in a large family with the WNK1 deletion mutation. Am J Med 114: 495-498, 2003.
2. Anast CS, Mohs JM, Kaplan SL, and Burns TW. Evidence for parathyroid failure in magnesium deficiency. Science 177: 606-608, 1972.
3. Bettinelli A, Bianchetti MG, Girardin E, Caringella A, Cecconi M, Appiani AC, Pavanello L, Gastaldi R, Isimbaldi C, Lama G, Marchesoni C, Matteucci C, Patriarcha P, Di Natale B, Setzu C, and Vitucci P. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr 120: 38-43, 1992.
4. Brown EM and MacLeod RJ. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81: 239-297, 2001.
5. Clapham DE, Runnels LW, and Strubing C. The TRP ion channel family. Nat Rev Neurosci 2: 387-396, 2001.
6. Cole DE and Quamme GA. Inherited disorders of renal magnesium handling. J Am Soc Nephrol 11: 1937-1947, 2000.
7. Colegio OR, Van Itallie CM, McCrea HJ, Rahner C, and Anderson JM. Claudins create charge-selective channels in the paracellular pathway between epithelial cells. Am J Physiol Cell Physiol 283: C142-C147, 2002.
8. Dai LJ, Ritchie G, Kerstan D, Kang HS, Cole DE, and Quamme GA. Magnesium transport in the renal distal convoluted tubule. Physiol Rev 81: 51-84, 2001.
9. De Rouffignac C and Quamme G. Renal magnesium handling and its hormonal control. Physiol Rev 74: 305-322, 1994.
10. Den Dekker E, Hoenderop JG, Nilius B, Bindels RJ, Vennekens R, Muller D, Prenen J, and Droogmans G. The epithelial calcium channels, TRPV5 and TRPV6: from identification towards regulation. Cell Calcium 33: 497-507, 2003.
11. Elin RJ. Magnesium: the fifth but forgotten electrolyte. Am J Clin Pathol 102: 616-622, 1994.
12. Fine KD, Santa Ana CA, Porter JL, and Fordtran JS. Intestinal absorption of magnesium from food and supplements. J Clin Invest 88: 396-402, 1991.
13. 2+ current impairs agonist-dependent vasorelaxation in TRP4-/- mice. Nat Cell Biol 3: 121-127, 2001.
14. Freitag JJ, Martin KJ, Conrades MB, Bellorin-Font E, Teitelbaum S, Klahr S, and Slatopolsky E. Evidence for skeletal resistance to parathyroid hormone in magnesium deficiency. Studies in isolated perfused bone. J Clin Invest 64: 1238-1244, 1979.
15. Goel M, Sinkins WG, and Schilling WP. Selective association of TRPC channel subunits in rat brain synaptosomes. J Biol Chem 277: 48303-48310, 2002.
16. Grimm C, Kraft R, Sauerbruch S, Schultz G, Harteneck C, Goel M, Sinkins WG, and Schilling WP. Molecular and functional characterization of the melastatin-related cation channel TRPM3. J Biol Chem 278: 21493-21501, 2003.
17. 2+-permeable channel activated by changes in redox status confers susceptibility to cell death. Mol Cell 9: 163-173, 2002.
18. Hardie RC, Raghu P, Imoto K, and Mori Y. Visual transduction in Drosophila. Nature 413: 186-193, 2001.
19. 3-responsive epithelia. J Biol Chem 274: 8375-8378, 1999.
20. 2+ channel family: comparison of mammalian ECaC1 and 2. J Physiol 537: 747-761, 2001.
21. 2+-activated monovalent selective cation channel (VCAM). Curr Biol 13: 1153-1158, 2003.
22. Hofmann T, Schaefer M, Schultz G, and Gudermann T. Subunit composition of mammalian transient receptor potential channels in living cells. Proc Natl Acad Sci USA 99: 7461-7466, 2002.
23. Hofmann T, Schaefer M, Schultz G, and Gudermann T. Transient receptor potential channels as molecular substrates of receptor-mediated cation entry. J Mol Med 78: 14-25, 2000.
24. 2+-permeable cation channel. Circ Res 88: 325-332, 2001.
25. Kerstan D and Quamme G. Physiology and pathophysiology of intestinal absorption of magnesium. In: Calcium in Internal Medicine, edited by Massry SG, Morii H, and Nishizawa Y. London: Springer-Verlag, 2002, p. 171-183.
26. Konrad M and Weber S. Recent advances in molecular genetics of hereditary magnesium-losing disorders. J Am Soc Nephrol 14: 249-260, 2003.
27. 2+-activated nonselective cation channel mediating cell membrane depolarization. Cell 109: 397-407, 2002.
28. Lee N, Chen J, Sun L, Wu S, Gray KR, Rich A, Huang M, Lin JH, Feder JN, Janovitz EB, Levesque PC, and Blanar MA. Expression and characterization of human transient receptor potential melastatin 3 (hTRPM3). J Biol Chem 278: 20890-20897, 2003.
29. Leypold BG, Yu CR, Leinders-Zufall T, Kim MM, Zufall F, Axel R, Onoue H, Hara Y, Shimizu S, Naitoh S, Ito Y, and Mori Y. Altered sexual and social behaviors in trp2 mutant mice. Proc Natl Acad Sci USA 99: 6376-6381, 2002.
30. Loffing J, Loffing-Cueni D, Hegyi I, Kaplan MR, Hebert SC, Le Hir M, and Kaissling B. Thiazide treatment of rats provokes apoptosis in distal tubule cells. Kidney Int 50: 1180-1190, 1996.
31. Marx SJ, Attie MF, Levine MA, Spiegel AM, Downs RW Jr, and Lasker RD. The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine (Baltimore) 60: 397-412, 1981.
32. Matzkin H, Lotan D, and Boichis H. Primary hypomagnesemia with a probable double magnesium transport defect. Nephron 52: 83-86, 1989.
33. Mayan H, Vered I, Mouallem M, Tzadok-Witkon M, Pauzner R, and Farfel Z. Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab 87: 3248-3254, 2002.
34. +-ATPase γ-subunit. Nat Genet 26: 265-266, 2000.
35. Michelis MF, Bragdon RW, Fusco RD, Eichenholz A, and Davis BB. Parathyroid hormone responsiveness in hypoparathyroidism with hypomagnesemia. Am J Med Sci 270: 412-418, 1975.
36. Milla PJ, Aggett PJ, Wolff OH, and Harries JT. Studies in primary hypomagnesaemia: evidence for defective carrier-mediated small intestinal transport of magnesium. Gut 20: 1028-1033, 1979.
37. Monteilh-Zoller MK, Hermosura MC, Nadler MJ, Scharenberg AM, Penner R, and Fleig A. TRPM7 provides an ion channel mechanism for cellular entry of trace metal ions. J Gen Physiol 121: 49-60, 2003.
38. Montell C. Physiology, phylogeny, and functions of the TRP superfamily of cation channels. Sci STKE 2001: RE1, 2001.
39. Montell C, Birnbaumer L, and Flockerzi V. The TRP channels, a remarkably functional family. Cell 108: 595-598, 2002.
40. Nadler MJ, Hermosura MC, Inabe K, Perraud AL, Zhu Q, Stokes AJ, Kurosaki T, Kinet JP, Penner R, Scharenberg AM, and Fleig A. LTRPC7 is a Mg ATP-regulated divalent cation channel required for cell viability. Nature 411: 590-595, 2001.
41. 2+ activated cation channel TRPM4. J Biol Chem 278: 30813-30820, 2003.
42. Nilius B, Watanabe H, Vriens J, Freichel M, Wissenbach U, Flockerzi V, and Montell C. The TRPV4 channel: structure-function relationship and promiscuous gating behaviour. Pflügers Arch 446: 298-303, 2003.
43. Paunier L, Radde IC, Kooh SW, Conen PE, and Fraser D. Primary hypomagnesemia with secondary hypocalcemia in an infant. Pediatrics 41: 385-402, 1968.
44. Pearce SH, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P, Brown EM, and Thakker RV. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 335: 1115-1122, 1996.
45. Peng JB, Chen XZ, Berger UV, Vassilev PM, Tsukaguchi H, Brown EM, and Hediger MA. Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption. J Biol Chem 274: 22739-22746, 1999.
46. Perraud AL, Fleig A, Dunn CA, Bagley LA, Launay P, Schmitz C, Stokes AJ, Zhu Q, Bessman MJ, Penner R, Kinet JP, and Scharenberg AM. ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology. Nature 411: 595-599, 2001.
47. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75: 1297-1303, 1993.
48. 2+-sensing receptor gene mutation. Nat Genet 8: 303-307, 1994.
49. Pu HX, Scanzano R, and Blostein R. Distinct regulatory effects of the Na,K-ATPase γ subunit. J Biol Chem 277: 20270-20276, 2002.
50. Quamme GA. Renal magnesium handling: new insights in understanding old problems. Kidney Int 52: 1180-1195, 1997.
51. Quamme GA and de Rouffignac C. Epithelial magnesium transport and regulation by the kidney. Front Biosci 5: D694-D711, 2000.
52. Rodriguez-Soriano J and Vallo A. Pathophysiology of the renal acidification defect present in the syndrome of familial hypomagnesaemia-hypercalciuria. Pediatr Nephrol 8: 431-435, 1994.
53. Rude RK, Oldham SB, and Singer FR. Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency. Clin Endocrinol (Oxf) 5: 209-224, 1976.
54. Runnels LW, Yue L, and Clapham DE. TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science 291: 1043-1047, 2001.
55. 2+ influx system mediated by LTRPC2. Science 293: 1327-1330, 2001.
56. Schlingmann KP, Weber S, Peters M, Niemann Nejsum L, Vitzthum H, Klingel K, Kratz M, Haddad E, Ristoff E, Dinour D, Syrrou M, Nielsen S, Sassen M, Waldegger S, Seyberth HW, and Konrad M. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 31: 166-170, 2002.
57. 2+ homeostasis by TRPM7. Cell 114: 191-200, 2003.
58. Shalev H, Phillip M, Galil A, Carmi R, and Landau D. Clinical presentation and outcome in primary familial hypomagnesaemia. Arch Dis Child 78: 127-130, 1998.
59. Shin J, Cho H, Hwang SW, Jung J, Shin CY, Lee SY, Kim SH, Lee MG, Choi YH, Kim J, Haber NA, Reichling DB, Khasar S, Levine JD, and Oh U. Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci USA 99: 10150-10155, 2002.
60. 2+ resorption. Science 285: 103-106, 1999.
61. Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, Vaara I, Iwata F, Cushner HM, Koolen M, Gainza FJ, Gitleman HJ, and Lifton RP. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 12: 24-30, 1996.
62. Stowers L, Holy TE, Meister M, Dulac C, and Koentges G. Loss of sex discrimination and male-male aggression in mice deficient for TRP2. Science 295: 1493-1500, 2002.
63. Van Itallie C, Rahner C, and Anderson JM. Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest 107: 1319-1327, 2001.
64. Vannier B, Zhu X, Brown D, and Birnbaumer L. The membrane topology of human transient receptor potential 3 as inferred from glycosylation-scanning mutagenesis and epitope immunocytochemistry. J Biol Chem 273: 8675-8679, 1998.
65. 2+ absorption. J Biol Chem. In press.
66. Voets T, Nilius B, Vannier B, Zhu X, Brown D, and Birnbaumer L. TRPs make sense. J Membr Biol 192: 1-8, 2003.
67. Walder RY, Borochowitz Z, Shalev H, Carmi R, Elbedour K, Scott DA, Stone EM, and Sheffield VC. Hypomagnesemia with secondary hypocalcemia (HSH): narrowing the disease region on chromosome 9 (Abstract). Am J Hum Genet 65: A451, 1999.
68. Walder RY, Landau D, Meyer P, Shalev H, Tsolia M, Borochowitz Z, Boettger MB, Beck GE, Englehardt RK, Carmi R, and Sheffield VC. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet 31: 171-174, 2002.
69. Walder RY, Shalev H, Brennan TM, Carmi R, Elbedour K, Scott DA, Hanauer A, Mark AL, Patil S, Stone EM, and Sheffield VC. Familial hypomagnesemia maps to chromosome 9q, not to the X chromosome: genetic linkage mapping and analysis of a balanced translocation breakpoint. Hum Mol Genet 6: 1491-1497, 1997.
70. Welsh DG, Morielli AD, Nelson MT, and Brayden JE. Transient receptor potential channels regulate myogenic tone of resistance arteries. Circ Res 90: 248-250, 2002.
71. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, and Lifton RP. Human hypertension caused by mutations in WNK kinases. Science 293: 1107-1112, 2001.
72. Wong V and Goodenough DA. Paracellular channels! Science 285: 62, 1999.
73. Xu XZ, Moebius F, Gill DL, and Montell C. Regulation of melastatin, a TRP-related protein, through interaction with a cytoplasmic isoform. Proc Natl Acad Sci USA 98: 10692-10697, 2001.
74. Yamaguchi H, Matsushita M, Nairn AC, and Kuriyan J. Crystal structure of the atypical protein kinase domain of a TRP channel with phosphotransferase activity. Mol Cell 7: 1047-1057, 2001.
75. Yang CL, Angell J, Mitchell R, and Ellison DH. WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 111: 1039-1045, 2003.
76. Yue L, Peng JB, Hediger MA, and Clapham DE. CaT1 manifests the pore properties of the calcium-release-activated calcium channel. Nature 410: 705-709, 2001.
77. Zhang Y, Hoon MA, Chandrashekar J, Mueller KL, Cook B, Wu D, Zuker CS, and Ryba NJ. Coding of sweet, bitter, and umami tastes: different receptor cells sharing similar signaling pathways. Cell 112: 293-301, 2003.